Johnson & Johnson (JNJ)

Johnson & Johnson's earnings dropped roughly 96% from a year ago, even as sales grew nearly 6%.

What is going on right now?

The price rose about 4% over the past week, sitting a bit above where it started the month but still below where it was a few weeks back.

How is the business itself doing?

J&J makes medicines and medical devices, and it keeps about 68 cents of every dollar after making its products. Sales are growing, but reported profits fell sharply, likely distorted by large one-time costs rather than a collapse in the actual business.

What stands out?

The company generated $18.5 billion in cash and carries modest debt, about half of what it owns outright. It also pays out roughly 80% of its earnings as dividends.

What comes next?

The next earnings report will show whether that dramatic profit drop was temporary or carries into a second quarter.